Related Experiment Video
Updated: Dec 8, 2025

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19
Published on: July 5, 2022
Relationships between hyperinsulinaemia, magnesium, vitamin D, thrombosis and COVID-19: rationale for clinical
Isabella D Cooper1, Catherine A P Crofts2, James J DiNicolantonio3
1School of Life Sciences, University of Westminster - Cavendish Campus, London, UK bellamitochondria@gmail.com.
Insights
Hyperinsulinaemia, a risk factor in COVID-19, drives poor outcomes by promoting inflammation and thrombosis. Dietary carbohydrate restriction with magnesium, vitamin D, and zinc supplementation can manage these risks.
Area of Science:
- Endocrinology
- Metabolic Syndrome
- COVID-19 Pathophysiology
Background:
- Pre-existing conditions like obesity, type 2 diabetes, and cardiovascular disease are linked to severe COVID-19 outcomes.
- Hyperinsulinaemia is identified as a common underlying factor contributing to these conditions and associated thrombotic events.
- Vitamin D activation is dependent on magnesium, and hyperinsulinaemia disrupts this process.
Purpose of the Study:
- To elucidate the role of hyperinsulinaemia in COVID-19 pathophysiology, particularly its links to thrombosis and poor outcomes.
- To propose a theoretical management algorithm for frontline practitioners based on the underlying science.
- To investigate the impact of hyperinsulinaemia on magnesium and vitamin D status.
Main Methods:
- Review of existing scientific literature on hyperinsulinaemia, metabolic dysfunction, and COVID-19.
- Analysis of biochemical pathways linking hyperinsulinaemia to inflammation, coagulation, and thrombosis.
- Development of a management strategy based on dietary and supplemental interventions.
Main Results:
- Hyperinsulinaemia contributes to thrombosis via fibrinolysis inhibition, dysregulated anticoagulation, oxidative stress, and decreased antioxidant capacity.
- It also impairs vitamin D activation by depleting magnesium and sequestering vitamin D in adipocytes.
- Hyperinsulinaemia-induced changes in cholesterol metabolism and cell membrane charge increase agglutination and thrombosis risk.
Conclusions:
- Restricting refined carbohydrates in COVID-19 patients with hyperglycaemia/hyperinsulinaemia can rapidly manage key risk factors.
- This dietary intervention, alongside magnesium, vitamin D, and zinc supplementation, addresses hyperinsulinaemia, hyperglycaemia, and hypertension, thereby reducing inflammation and thrombosis risk.
- The proposed management algorithm offers a practical approach for frontline practitioners to mitigate severe COVID-19 outcomes.
Abstract:
Risk factors for COVID-19 patients with poorer outcomes include pre-existing conditions: obesity, type 2 diabetes mellitus, cardiovascular disease (CVD), heart failure, hypertension, low oxygen saturation capacity, cancer, elevated: ferritin, C reactive protein (CRP) and D-dimer. A common denominator, hyperinsulinaemia, provides a plausible mechanism of action, underlying CVD, hypertension and strokes, all conditions typified with thrombi. The underlying science provides a theoretical management algorithm for the frontline practitioners.Vitamin D activation requires magnesium. Hyperinsulinaemia promotes: magnesium depletion via increased renal excretion, reduced intracellular levels, lowers vitamin D status via sequestration into adipocytes and hydroxylation activation inhibition. Hyperinsulinaemia mediates thrombi development via: fibrinolysis inhibition, anticoagulation production dysregulation, increasing reactive oxygen species, decreased antioxidant capacity via nicotinamide adenine dinucleotide depletion, haem oxidation and catabolism, producing carbon monoxide, increasing deep vein thrombosis risk and pulmonary emboli. Increased haem-synthesis demand upregulates carbon dioxide production, decreasing oxygen saturation capacity. Hyperinsulinaemia decreases cholesterol sulfurylation to cholesterol sulfate, as low vitamin D regulation due to magnesium depletion and/or vitamin D sequestration and/or diminished activation capacity decreases sulfotransferase enzyme SULT2B1b activity, consequently decreasing plasma membrane negative charge between red blood cells, platelets and endothelial cells, thus increasing agglutination and thrombosis.Patients with COVID-19 admitted with hyperglycaemia and/or hyperinsulinaemia should be placed on a restricted refined carbohydrate diet, with limited use of intravenous dextrose solutions. Degree/level of restriction is determined by serial testing of blood glucose, insulin and ketones. Supplemental magnesium, vitamin D and zinc should be administered. By implementing refined carbohydrate restriction, three primary risk factors, hyperinsulinaemia, hyperglycaemia and hypertension, that increase inflammation, coagulation and thrombosis risk are rapidly managed.
Related Concept Videos
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Myocarditis III: Medical Management
Hypertension III: Clinical Manifestations and Diagnostic Studies
Acute Pancreatitis II: Clinical Manifestations and Management
Diabetes Mellitus: Type 2 and Gestational
Atherosclerosis III: Management

